Firstly, we demonstrated that intratumoral heterogeneity can be a major confounding factor when assessing PD-L1 status in SCCHN: a substantial amount of primary tumor biopsies were found to have discordant CPS compared to their paired resection specimens. This evidence concerns the gene CD274 and neoplasm.